Actively Recruiting
Prodromal Parkinsonian Features in GBA1 Mutation Carriers
Led by Shaare Zedek Medical Center · Updated on 2026-04-29
600
Participants Needed
1
Research Sites
711 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Objective of the trial. To define a sub-population which is at increased risk of developing Parkinson, beyond the fact of carrying Gaucher; in this sub-population the investigators shall conduct a comprehensive evaluation that includes a variety of non-invasive tests, whose purpose is to evaluate the state of the pre- Parkinson's disease signs, signs which can appear, even twenty years before the appearance of the disease, and also to compare them to a group of diagnosed Gaucher patients and a group of healthy people who are not carriers of Gaucher disease. A group of those carriers will be available for trial or for treatment, if there will be a medicine for the prevention of the development of Parkinson, obtainable.
CONDITIONS
Official Title
Prodromal Parkinsonian Features in GBA1 Mutation Carriers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing to participate
You will not qualify if you...
- Diagnosis of Parkinson's disease
- Diagnosis of dementia
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Michal Becker- Cohen
Jerusalem, Please Select..., Israel, 9103102
Actively Recruiting
Research Team
A
Ari Zimran, MD
CONTACT
M
Michal Becker- Cohen, M.Sc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here